Literature DB >> 26831195

Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.

Karsten Heusser1, Jens Tank1, Julia Brinkmann1, Jan Menne1, Jessica Kaufeld1, Silvia Linnenweber-Held1, Joachim Beige1, Mathias Wilhelmi1, André Diedrich1, Hermann Haller1, Jens Jordan2.   

Abstract

Bilateral bipolar electric carotid sinus stimulation acutely reduced muscle sympathetic nerve activity (MSNA) and blood pressure (BP) in patients with resistant arterial hypertension but is no longer available. The second-generation device uses a smaller unilateral unipolar disk electrode to reduce invasiveness while saving battery life. We hypothesized that the second-generation device acutely lowers BP and MSNA in treatment-resistant hypertensive patients. Eighteen treatment-resistant hypertensive patients (9 women/9 men; 53±11 years; 33±5 kg/m(2)) on stable medications have been included in the study. We monitored finger and brachial BP, heart rate, and MSNA. Without stimulation, BP was 165±31/91±18 mm Hg, heart rate was 75±17 bpm, and MSNA was 48±14 bursts per minute. Acute stimulation with intensities producing side effects that were tolerable in the short term elicited interindividually variable changes in systolic BP (-16.9±15.0 mm Hg; range, 0.0 to -40.8 mm Hg; P=0.002), heart rate (-3.6±3.6 bpm; P=0.004), and MSNA (-2.0±5.8 bursts per minute; P=0.375). Stimulation intensities had to be lowered in 12 patients to avoid side effects at the expense of efficacy (systolic BP, -6.3±7.0 mm Hg; range, 2.8 to -14.5 mm Hg; P=0.028 and heart rate, -1.5±2.3 bpm; P=0.078; comparison against responses with side effects). Reductions in diastolic BP and MSNA (total activity) were correlated (r(2)=0.329; P=0.025). In our patient cohort, unilateral unipolar electric baroreflex stimulation acutely lowered BP. However, side effects may limit efficacy. The approach should be tested in a controlled comparative study.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  autonomic nervous system; baroreflex; carotid sinus; electrodes; heart rate; hypertension; pressoreceptors

Mesh:

Substances:

Year:  2016        PMID: 26831195      PMCID: PMC4773922          DOI: 10.1161/HYPERTENSIONAHA.115.06486

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

1.  Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

2.  Assessment of baroreceptor reflex sensitivity by means of spectral analysis.

Authors:  H W Robbe; L J Mulder; H Rüddel; W A Langewitz; J B Veldman; G Mulder
Journal:  Hypertension       Date:  1987-11       Impact factor: 10.190

3.  Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity.

Authors:  Krzysztof Narkiewicz; Bradley G Phillips; Masahiko Kato; Dagmara Hering; Leszek Bieniaszewski; Virend K Somers
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

4.  The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension.

Authors:  Murray Esler
Journal:  Exp Physiol       Date:  2011-05-06       Impact factor: 2.969

5.  Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.

Authors:  Karsten Heusser; Jens Tank; Andre Diedrich; Stefan Engeli; Susanne Klaua; Nadine Krüger; Anke Strauss; Gritt Stoffels; Friedrich C Luft; Jens Jordan
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

6.  Graded and dynamic reflex summation of myelinated and unmyelinated rat aortic baroreceptors.

Authors:  W Fan; J H Schild; M C Andresen
Journal:  Am J Physiol       Date:  1999-09

7.  Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.

Authors:  William T Abraham; Michael R Zile; Fred A Weaver; Christian Butter; Anique Ducharme; Marcel Halbach; Didier Klug; Eric G Lovett; Jochen Müller-Ehmsen; Jill E Schafer; Michele Senni; Vijay Swarup; Rolf Wachter; William C Little
Journal:  JACC Heart Fail       Date:  2015-05-14       Impact factor: 12.035

8.  Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.

Authors:  Michael R Zile; William T Abraham; Fred A Weaver; Christian Butter; Anique Ducharme; Marcel Halbach; Didier Klug; Eric G Lovett; Jochen Müller-Ehmsen; Jill E Schafer; Michele Senni; Vijay Swarup; Rolf Wachter; William C Little
Journal:  Eur J Heart Fail       Date:  2015-06-10       Impact factor: 15.534

9.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.

Authors:  Edoardo Gronda; Gino Seravalle; Gianmaria Brambilla; Giuseppe Costantino; Andrea Casini; Ali Alsheraei; Eric G Lovett; Giuseppe Mancia; Guido Grassi
Journal:  Eur J Heart Fail       Date:  2014-07-28       Impact factor: 15.534

View more
  24 in total

Review 1.  [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].

Authors:  M Wallbach; M J Koziolek; R Wachter
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

Review 2.  Resistant Hypertension: An Update of Experimental and Clinical Findings.

Authors:  Anping Cai; David A Calhoun
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

Review 3.  [Invasive treatment of hypertension : Update 2016].

Authors:  J Menne; R Wachter
Journal:  Internist (Berl)       Date:  2016-09       Impact factor: 0.743

Review 4.  Device-Based Approaches for the Treatment of Arterial Hypertension.

Authors:  Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

5.  Electrical carotid sinus stimulation may get lost in translation.

Authors:  Jens Jordan; Jens Tank
Journal:  Hypertens Res       Date:  2020-07-22       Impact factor: 3.872

Review 6.  Fifty years of microneurography: learning the language of the peripheral sympathetic nervous system in humans.

Authors:  J Kevin Shoemaker; Stephen A Klassen; Mark B Badrov; Paul J Fadel
Journal:  J Neurophysiol       Date:  2018-02-07       Impact factor: 2.714

7.  [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Authors:  M Koziolek; J Beige; M Wallbach; D Zenker; G Henning; M Halbach; N Mader; F Mahfoud; G Schlieper; V Schwenger; M Hausberg; J Börgel; M Lodde; M van der Giet; J Müller-Ehmsen; J Passauer; S Parmentier; S Lüders; B K Krämer; S Büttner; F Limbourg; J Jordan; O Vonend; H-G Predel; H Reuter
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

8.  Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.

Authors:  Drew A Hildebrandt; Eric D Irwin; Thomas E Lohmeier
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

Review 9.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

10.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.